Literature DB >> 9696870

Lipofection of purified adeno-associated virus Rep68 protein: toward a chromosome-targeting nonviral particle.

S Lamartina1, G Roscilli, D Rinaudo, P Delmastro, C Toniatti.   

Abstract

Adeno-associated virus (AAV) integrates very efficiently into a specific site (AAVS1) of human chromosome 19. Two elements of the AAV genome are sufficient: the inverted terminal repeats (ITRs) and the Rep78 or Rep68 protein. The incorporation of the AAV integration machinery in nonviral delivery systems is of great interest for gene therapy. We demonstrate that purified recombinant Rep68 protein is functionally active when directly delivered into human cells by using the polycationic liposome Lipofectamine, promoting the rescue-replication of a codelivered ITR-flanked cassette in adenovirus-infected cells and its site-specific integration in noninfected cells. The sequencing of cloned virus-host DNA junctions confirmed that lipofected Rep68 protein triggers site-specific integration at the same sites in chromosome 19 already characterized in cells latently infected with AAV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696870      PMCID: PMC110032     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Site-specific integration by adeno-associated virus: a basis for a potential gene therapy vector.

Authors:  R M Linden; K I Berns
Journal:  Gene Ther       Date:  1997-01       Impact factor: 5.250

2.  Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.

Authors:  W G Kearns; S A Afione; S B Fulmer; M C Pang; D Erikson; M Egan; M J Landrum; T R Flotte; G R Cutting
Journal:  Gene Ther       Date:  1996-09       Impact factor: 5.250

Review 3.  Site-specific integration by adeno-associated virus.

Authors:  R M Linden; P Ward; C Giraud; E Winocour; K I Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome.

Authors:  C Balagúe; M Kalla; W W Zhang
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Characterization of the Rep78/adeno-associated virus complex.

Authors:  K M Prasad; C Zhou; J P Trempe
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

6.  Cytoplasmic expression of a reporter gene by co-delivery of T7 RNA polymerase and T7 promoter sequence with cationic liposomes.

Authors:  X Gao; L Huang
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

7.  Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein.

Authors:  R O Snyder; D S Im; T Ni; X Xiao; R J Samulski; N Muzyczka
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization.

Authors:  D S Im; N Muzyczka
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Genomic targeting with purified Cre recombinase.

Authors:  W Baubonis; B Sauer
Journal:  Nucleic Acids Res       Date:  1993-05-11       Impact factor: 16.971

10.  Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination.

Authors:  R M Kotin; R M Linden; K I Berns
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  21 in total

1.  Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.

Authors:  A Recchia; R J Parks; S Lamartina; C Toniatti; L Pieroni; F Palombo; G Ciliberto; F L Graham; R Cortese; N La Monica; S Colloca
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 2.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

3.  Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein.

Authors:  D Rinaudo; S Lamartina; G Roscilli; G Ciliberto; C Toniatti
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 4.  Targeting site-specific chromosome integration.

Authors:  Patricia Nuno-Gonzalez; Hsu Chao; Kazuhiro Oka
Journal:  Acta Biochim Pol       Date:  2005-06-03       Impact factor: 2.149

5.  The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly.

Authors:  Annie M Bruns; George P Leser; Robert A Lamb; Curt M Horvath
Journal:  Mol Cell       Date:  2014-08-07       Impact factor: 17.970

6.  Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeutics.

Authors:  Gwendolyn M Wilmes; Kimberly L Carey; Stuart W Hicks; Hugh H Russell; Jesse A Stevenson; Paulina Kocjan; Stephen R Lutz; Rachel S Quesenberry; Sergey V Shulga-Morskoy; Megan E Lewis; Ethan Clark; Violetta Medik; Anthony B Cooper; Elizabeth E Reczek
Journal:  MAbs       Date:  2014-04-23       Impact factor: 5.857

7.  Characteristics of the adeno-associated virus preintegration site in human chromosome 19: open chromatin conformation and transcription-competent environment.

Authors:  S Lamartina; E Sporeno; E Fattori; C Toniatti
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction.

Authors:  Anna C Maurer; Matthew D Weitzman
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

9.  A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19.

Authors:  Nicola J Philpott; Janette Gomos; Kenneth I Berns; Erik Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

10.  Development of animal models for adeno-associated virus site-specific integration.

Authors:  G Rizzuto; B Gorgoni; M Cappelletti; D Lazzaro; I Gloaguen; V Poli; A Sgura; D Cimini; G Ciliberto; R Cortese; E Fattori; N La Monica
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.